LIN vs PATH
Linde plc Ordinary Shares (LIN) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the LIN and PATH stock pages for the full models.
Not investment advice.